Immunological Outcomes Posted byjascallyJuly 15, 2021Posted inIvermectin, Virus Attenuation of clinical and immunological outcomes during SARS‐CoV‐2 infection by ivermectin | EMBO Molecular Medicine (embopress.org) Share this: Click to share on X (Opens in new window) X Click to share on Facebook (Opens in new window) Facebook Like Loading... Related